Top 10 Companies in the 1,10‑Phenanthroline (CAS 66‑71‑7) Market (2026): Market Leaders Powering Global Demand

MARKET INSIGHTS

Global 1,10‑Phenanthroline (CAS 66‑71‑7) market size was valued at USD 320.4 million in 2025. The market is set to expand from USD 338.6 million in 2026 to USD 561.2 million by 2034, growing at a CAGR of 6.5 % during the forecast period.

1,10‑Phenanthroline is a heterocyclic organic compound widely recognized as a potent chelating agent with a strong affinity for transition metal ions, particularly iron, copper, and zinc. Its rigid planar structure enables the formation of highly stable metal complexes, making it a critical reagent across analytical chemistry, biochemistry, and materials science. The compound finds extensive application in colorimetric iron determination, DNA cleavage studies, corrosion inhibition, and as a ligand in the synthesis of coordination compounds and luminescent materials.

The market is witnessing steady expansion driven by growing demand from pharmaceutical research, water quality testing laboratories, and the semiconductor industry. Furthermore, increasing investments in coordination chemistry and the rising use of 1,10‑Phenanthroline as a precursor in the development of anticancer metal complexes are reinforcing market momentum. Key industry participants including Sigma‑Aldrich (Merck KGaA), Thermo Fisher Scientific, and TCI Chemicals continue to maintain robust product portfolios catering to research and industrial‑grade applications globally.

1,10‑Phenanthroline (CAS 66‑71‑7) Market – View in Detailed Research Report

Top 10 Companies in the 1,10‑Phenanthroline (CAS 66‑71‑7) Market (2026)

1. Merck KGaA (Sigma‑Aldrich)
   Headquarters: Darmstadt, Germany
   Key Offering: Comprehensive range of reagent‑grade, pharmaceutical‑grade, and industrial‑grade 1,10‑Phenanthroline, including anhydrous and monohydrate forms.
   Merck KGaA leverages its global R&D network to deliver consistently high purity reagents that meet stringent regulatory standards across analytical chemistry, pharmaceutical synthesis, and advanced materials research. The company’s investment in automated purification lines and real‑time quality monitoring ensures batch‑to‑batch reproducibility that is critical for drug discovery and OEM testing.
   Sustainability initiatives: Development of greener synthesis routes using aqueous media and recyclable catalysts; commitment to reducing solvent waste through closed‑loop recovery systems.

   • High‑purity catalogues for analytical labs
   • Pharmaceutical‑grade grades for pre‑clinical studies
   • Custom synthesis capabilities for complex ligands

2. Thermo Fisher Scientific (Alfa Aesar / Acros Organics)
   Headquarters: Waltham, USA
   Key Offering: Broad portfolio of 1,10‑Phenanthroline grades with extensive technical data sheets, coupled with a robust distribution network.
   Thermo Fisher’s integrated supply chain delivers rapid turnaround times and on‑site technical support, positioning the company as the preferred supplier for laboratories that require high‑throughput analytical workflows. The firm’s partnership with academic institutions facilitates access to new ligand‑based research projects, driving demand for specialty grades.
   Sustainability initiatives: Implementation of energy‑efficient manufacturing processes; participation in the Chemical Management Initiative to reduce hazardous waste.

   • Reagent‑grade for spectrophotometry
   • Pharmaceutical‑grade for drug‑delivery research
   • Bulk industrial grades for OEMs

3. Tokyo Chemical Industry Co., Ltd. (TCI)
   Headquarters: Tokyo, Japan
   Key Offering: Premium 1,10‑Phenanthroline reagents and custom synthesis services for specialty applications.
   TCI’s focus on high‑purity chemistry supports the growing demand in OLEDs and metal‑organic framework research. The company’s lean manufacturing model and close collaboration with semiconductor fabs enable rapid scaling of production volumes for critical research and development cycles.
   Sustainability initiatives: Adoption of low‑VOC solvents and implementation of waste‑heat recovery systems.

   • Ultra‑pure grades for OLED manufacturing
   • Custom ligand synthesis for coordination chemistry
   • Technical grades for industrial use

4. Jiangsu Yuanyang Pharmaceutical Co., Ltd.
   Headquarters: Jiangsu, China
   Key Offering: Cost‑effective bulk 1,10‑Phenanthroline with scalable production capabilities.
   The company’s integrated supply chain, anchored by a domestic o‑phenylenediamine sourcing network, allows it to meet high‑volume demands from the pharmaceutical and agrochemical sectors. Its emphasis on cost efficiency has positioned it as a preferred partner for generic manufacturers and large‑scale analytical labs.
   Sustainability initiatives: Implementation of water‑recycling units and adoption of greener raw‑material sources.

   • Bulk industrial grades for OEMs
   • Reagent‑grade for academic labs
   • Pharmaceutical‑grade for early‑stage development

5. Hangzhou Dayangchem Co., Ltd.
   Headquarters: Hangzhou, China
   Key Offering: Flexible production of anhydrous and monohydrate 1,10‑Phenanthroline tailored to customer specifications.
   Hangzhou Dayangchem’s modular synthesis lines enable rapid adaptation to emerging market segments such as OLEDs and anticancer ligand research. The firm’s focus on quality documentation supports compliance with international regulatory frameworks, making it a reliable partner for global buyers.
   Sustainability initiatives: Deployment of renewable energy sources in production facilities; commitment to ISO 14001 environmental management.

   • Reagent‑grade for analytical labs
   • Pharmaceutical‑grade for research
   • Industrial‑grade for OEMs

6. Fluorochem Ltd.
   Headquarters: London, UK
   Key Offering: Specialty 1,10‑Phenanthroline grades with high purity and trace‑metal control.
   Fluorochem’s niche positioning serves advanced research in coordination chemistry and materials science, where even minor impurities can compromise performance. The company’s collaboration with European universities ensures early access to emerging applications such as MOFs and luminescent sensors.
   Sustainability initiatives: Use of biodegradable solvents and strict emissions controls.

   • Ultra‑pure grades for research
   • Technical grades for industrial use

7. Strem Chemicals, Inc.
   Headquarters: Wilmington, USA
   Key Offering: High‑purity 1,10‑Phenanthroline and custom synthesis for specialty projects.
   Strem’s focus on clean‑room compatible reagents supports semiconductor fabs and OLED manufacturers. The company’s rapid prototyping capabilities allow it to respond quickly to experimental demands in catalytic and sensor research.
   Sustainability initiatives: Implementation of closed‑loop solvent recovery; reduction of hazardous waste streams.

   • Reagent‑grade for analytical chemistry
   • Custom ligand synthesis for advanced materials

8. Carbosynth Limited
   Headquarters: Oxford, UK
   Key Offering: High‑purity 1,10‑Phenanthroline with detailed characterization data.
   Carbosynth’s reputation for rigorous analytical support makes it a trusted supplier for pharmaceutical R&D and academic research. The firm’s investment in high‑throughput synthesis platforms accelerates the development of new ligand architectures.
   Sustainability initiatives: Adoption of green chemistry principles; use of renewable feedstocks.

   • Reagent‑grade for laboratories
   • Pharmaceutical‑grade for drug discovery

9. Glentham Life Sciences Ltd.
   Headquarters: Cambridge, UK
   Key Offering: Custom 1,10‑Phenanthroline synthesis and analytical support services.
   Glentham’s integrated approach combines synthesis, characterization, and quality assurance, enabling it to serve niche markets such as OLEDs and corrosion inhibitors. The company’s focus on precision chemistry ensures that even the most demanding applications receive the required purity levels.
   Sustainability initiatives: Implementation of low‑energy processes and waste minimization strategies.

   • Custom synthesis for OLEDs
   • Bulk supply for industrial applications

10. Sinopharm Chemical Reagent Co., Ltd.
    Headquarters: Beijing, China
    Key Offering: Scalable production of 1,10‑Phenanthroline for pharmaceutical and analytical markets.
    Sinopharm’s extensive distribution network across China supports rapid deployment to research institutions and OEMs. The company’s focus on quality certification aligns with both domestic and international regulatory requirements, enhancing its competitiveness in global markets.
    Sustainability initiatives: Integration of water‑recycling systems and energy‑efficient production.

    • Bulk industrial grades for OEMs
    • Reagent‑grade for academic labs
    • Pharmaceutical‑grade for drug development

Download FREE Sample Report: 1,10‑Phenanthroline (CAS 66‑71‑7) Market

Get Full Report: 1,10‑Phenanthroline (CAS 66‑71‑7) Market

Outlook

Over the next decade, the 1,10‑Phenanthroline market will be shaped by the convergence of analytical chemistry, pharmaceutical research, and advanced materials. The expanding demand for high‑purity reagents in OLED manufacturing and metal‑organic frameworks will drive volume growth, while the pharmaceutical sector’s pursuit of novel anticancer metal complexes will sustain premium‑grade consumption. Geographic diversification will see Asia‑Pacific maintain its leadership in volume, whereas North America and Europe will focus on high‑value applications and regulatory compliance.

Future Trends

• Integration of 1,10‑Phenanthroline‑based ligands into next‑generation OLEDs and perovskite solar cells.
• Emergence of metal‑phenanthroline complexes as selective imaging agents in oncology diagnostics.
• Adoption of green synthesis protocols to reduce solvent use and improve sustainability across the supply chain.
• Expansion of automated, high‑throughput screening platforms that rely on 1,10‑Phenanthroline for rapid metal‑complex formation.
• Increased focus on supply‑chain resilience, prompting strategic partnerships between manufacturers and distributors to mitigate raw‑material volatility.